Business Standard

Aarti Pharmalabs Ltd Announcements

BY EXCHANGE :

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
04/04/2024| bse
Compliance Certificate For The Financial Year Ended March 31 2024
04/04/2024| bse
Closure of Trading Window
27/03/2024| bse
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
13/02/2024| bse
Announcement under Regulation 30 (LODR)-Newspaper Publication
09/02/2024| bse
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
08/02/2024| bse
Announcement under Regulation 30 (LODR)-Investor Presentation
08/02/2024| bse
Corporate Action-Board approves Dividend
07/02/2024| bse
Record Date For Interim Dividend
07/02/2024| bse
Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2023
07/02/2024| bse
Board Meeting Outcome for Board Meeting Outcome For Financial Results And Interim Dividend
07/02/2024| bse
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
01/02/2024| bse
Board Meeting Intimation for Audited Financial Results For The Quarter And Nine Months Ended December 31 2023 Interim Dividend If Any For The FY 2023-24 And Other Business Matters If Any.
30/01/2024| bse
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08/01/2024| bse
Intimation Of Grant Of Options Under APL Performance Stock Option Plan 2023
04/01/2024| bse
Announcement under Regulation 30 (LODR)-Newspaper Publication
23/08/2023| bse
Business Responsibility and Sustainability Reporting (BRSR)
22/08/2023| bse
Notice Of The 4Th AGM - Thursday September 14 2023
22/08/2023| bse
Reg. 34 (1) Annual Report.
22/08/2023| bse
Announcement under Regulation 30 (LODR)-Newspaper Publication
21/08/2023| bse

Load more